Anti-FKBP11 monoclonal antibody

Pre-made anti-FKBP11 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to FKBP11/FKBP11 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0850-Ab-1/ GM-Tg-hg-IP0850-Ab-2Anti-Human FKBP11 monoclonal antibodyHuman
GM-Tg-rg-IP0850-Ab-1/ GM-Tg-rg-IP0850-Ab-2Anti-Rat FKBP11 monoclonal antibodyRat
GM-Tg-mg-IP0850-Ab-1/ GM-Tg-mg-IP0850-Ab-2Anti-Mouse FKBP11 monoclonal antibodyMouse
GM-Tg-cynog-IP0850-Ab-1/ GM-Tg-cynog-IP0850-Ab-2Anti-Cynomolgus/ Rhesus macaque FKBP11 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0850-Ab-1/ GM-Tg-felg-IP0850-Ab-2Anti-Feline FKBP11 monoclonal antibodyFeline
GM-Tg-cang-IP0850-Ab-1/ GM-Tg-cang-IP0850-Ab-2Anti-Canine FKBP11 monoclonal antibodyCanine
GM-Tg-bovg-IP0850-Ab-1/ GM-Tg-bovg-IP0850-Ab-2Anti-Bovine FKBP11 monoclonal antibodyBovine
GM-Tg-equg-IP0850-Ab-1/ GM-Tg-equg-IP0850-Ab-2Anti-Equine FKBP11 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0850-Ab-1/ GM-Tg-hg-IP0850-Ab-2; GM-Tg-rg-IP0850-Ab-1/ GM-Tg-rg-IP0850-Ab-2;
GM-Tg-mg-IP0850-Ab-1/ GM-Tg-mg-IP0850-Ab-2; GM-Tg-cynog-IP0850-Ab-1/ GM-Tg-cynog-IP0850-Ab-2;
GM-Tg-felg-IP0850-Ab-1/ GM-Tg-felg-IP0850-Ab-2; GM-Tg-cang-IP0850-Ab-1/ GM-Tg-cang-IP0850-Ab-2;
GM-Tg-bovg-IP0850-Ab-1/ GM-Tg-bovg-IP0850-Ab-2; GM-Tg-equg-IP0850-Ab-1/ GM-Tg-equg-IP0850-Ab-2
Products NameAnti-FKBP11 monoclonal antibody
Formatmab
Target NameFKBP11
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-FKBP11 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0850-Ag-1Recombinant multi-species FKB11/ FKBP11/ FKBP19 protein


    Target information

    Target IDGM-IP0850
    Target NameFKBP11
    Gene ID51303,66120,300211,708598,608951,101093115,506043,100058791
    Gene Symbol and Synonyms1110002O23Rik,FKBP-11,FKBP11,FKBP19
    Uniprot AccessionQ9NYL4,Q2YDL5
    Uniprot Entry NameFKB11_HUMAN,FKB11_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseProstate Cancer
    Gene EnsemblENSG00000134285
    Target ClassificationN/A

    The target: FKBP11, gene name: FKBP11, also named as FKBP19. FKBP11 belongs to the FKBP family of peptidyl-prolyl cis/trans isomerases, which catalyze the folding of proline-containing polypeptides. The peptidyl-prolyl isomerase activity of FKBP proteins is inhibited by the immunosuppressant compounds FK506 and rapamycin (Rulten et al., 2006 [PubMed 16596453]).[supplied by OMIM, Mar 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.